ClinicalTrials.Veeva

Menu

Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease

U

University Medical Centre Ljubljana

Status

Unknown

Conditions

Cyanotic Congenital Heart Disease
Paraganglioma
Acyanotic Congenital Heart Disease
Pheochromocytoma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of our study is to compare plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease and possible association with chronic hypoxic stress.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with congenital heart disease attending regular follow up

Exclusion criteria

  • missing main data in medical documentation

Trial design

50 participants in 2 patient groups

Patients with cyanotic Congenital Heart Disease
Patients with acyanotic Congenital Heart Disease

Trial contacts and locations

1

Loading...

Central trial contact

Mojca Jensterle, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems